NIO’s 4Q22 earnings missed our prior forecast on inventory provision, R&D and SG&A. We are of the view that NIO’s 1Q23E sales and margin weakness should be largely priced in.
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
Unlock research summaries
Follow top, independent analysts
Receive personalised alerts
Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.